Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Recode Therapeutics Inc.
Headquarters: Menlo Park, CA, United States of America
Website: https://recodetx.com/
Year Founded: 2014
Status: Private
BioCentury | Jul 5, 2024
Product Development
LNP innovation: tissue specificity, aided by AI
How LNP companies delivering nucleic acids are cracking the tissue tropism problem, and finding freedom to operate
BioCentury | Feb 21, 2024
Deals
Deal report: Astellas taps Kelonia for CAR Ts, Aurinia fails to find buyer, and more
Plus: Xoma-Kinnate, Almirall-Novo, Intellia-ReCode, Roche-Repare and more
BioCentury | Dec 12, 2023
Management Tracks
Kathy Dong named CEO of Electra
Plus: Angèle Maki named CBO at Hummingbird and an update from AviadoBio
BioCentury | Nov 17, 2023
Discovery & Translation
Boosting lymphatic drainage for TBI recovery; improved CASTs and more
BioCentury’s roundup of translational innovations
BioCentury | Nov 1, 2023
Finance
New VC Bioluminescence believes downturn offers ripe opportunity for platform investing
The firm’s founder, Kouki Harasaki, draws upon lessons from 2008 to guide investment thesis in current environment
BioCentury | Sep 20, 2023
Finance
Sept. 19 Quick Takes: RNA editing company Airna emerges with $30M round led by Arch
Plus: Longevity-focused VC debuts and updates from Recode, Merck, Taysha and Paratek
BioCentury | Jul 11, 2023
Management Tracks
Billy Cho joins CBC as senior managing director
Plus: Birchenough becomes chairman of global healthcare at Barclays, and updates from EyePoint, Replicate, MBX, Voyager and more
BioCentury | Apr 18, 2023
Management Tracks
Kjems becomes CMO at Ocelot
Plus: New CFO at RS and updates from Tessera and ReCode
BioCentury | Apr 12, 2023
Politics, Policy & Law
Opposition to Texas mifepristone ruling unites biotechs
Biotech Sisters leading industry response
BioCentury | Feb 2, 2023
Management Tracks
Mendila takes up CDO role at CureVac
Plus: BMS, Merck vet Eid joins Dragonfly and updates from Ariceum, AviadoBio, Poseida and more
Items per page:
1 - 10 of 19